This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Disease Info Card
Sinus Histiocytosis
Information about Sinus Histiocytosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Sinus Histiocytosis
Most recent studies have shown that Sinus Histiocytosis shares some biological mechanisms with brain-diseases, carcinoma, dermatologic-disorders, granuloma, histiocytosis, histiocytosis-langerhans-cell, hyperplasia, lymphadenitis, lymphatic-diseases, lymphatic-metastasis, lymphoma, malignant-neoplasm-of-breast, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, meningioma, neoplasm-metastasis, neoplasms, nervousness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Sinus Histiocytosis, and have been seen in publications frequently: Cell Differentiation, Cell Migration, Cell Proliferation, Coagulation, Dendritic Cell Differentiation, Granuloma Formation, Hemostasis, Humoral Immune Response, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Lymphocyte Migration, Pathogenesis, Phagocytosis, Response To Methotrexate, Secretion, Shell Calcification, Transdifferentiation, Transport
Quite a number of genes have been found to play important roles in Sinus Histiocytosis, such as CD163, CD1A, CD1B, CD1C, CD4, CD68, CTLA4, ESR1, FAS, HLA-DQA1, KRT20, LYZ, MS4A1, NOD2, S100A1, S100B, SERPINA3, SLC29A3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.